Novo Nordisk AS

NYSE:NVOHealthcare

$38.42−1.06%At closeAt close · Tue 20 Oct · ≈ AED 141.10 · Market cap $172.98B · Next earnings Wed 4 Nov · Extended $38.47 +0.12%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	83.5%	83.2%	83.9%	84.6%	84.7%	81.0%	—	—
Operating margin	42.6%	41.7%	42.3%	44.2%	44.2%	41.3%	41.3%	+0.0 pts
Net margin	33.2%	33.9%	31.4%	36.0%	34.8%	33.1%	33.1%	+0.0 pts
EBITDA margin	46.7%	46.4%	43.4%	49.4%	50.9%	50.7%	—	—
Return on equity	404.8%	67.5%	66.5%	78.5%	70.4%	52.8%	52.8%	+0.0 pts
Return on assets	176.9%	24.6%	23.0%	26.6%	21.7%	18.9%	18.9%	+0.0 pts
Return on capital employed	441.1%	61.7%	62.2%	70.8%	51.7%	39.0%	—	—
Debt / equity	0.2×	0.4×	0.3×	0.3×	0.7×	0.7×	0.7×	+0.0%
Debt / assets	7.1%	13.7%	10.7%	8.6%	22.1%	24.1%	—	—
Interest coverage	138.8×	202.9×	197.9×	189.3×	78.3×	30.3×	—	—
Current ratio	0.9×	0.9×	0.9×	0.8×	0.7×	0.8×	0.8×	+0.0%
Quick ratio	0.7×	0.7×	0.7×	0.6×	0.6×	0.6×	—	—
Cash ratio	0.2×	0.1×	0.1×	0.1×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	5.3×	0.7×	0.7×	0.7×	0.6×	0.6×	—	—
Inventory turnover	6.9×	1.2×	1.2×	1.1×	1.1×	1.2×	—	—
Receivables turnover	27.6×	3.0×	3.1×	3.1×	3.3×	4.1×	—	—
Dividend payout	47.8%	45.1%	45.6%	38.0%	43.7%	50.5%	—	—